266 related articles for article (PubMed ID: 22458493)
41. Optimal surgical margin in nephron-sparing surgery for T1b renal cell carcinoma.
Chen XS; Zhang ZT; Du J; Bi XC; Sun G; Yao X
Urology; 2012 Apr; 79(4):836-9. PubMed ID: 22305422
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the RENAL nephrometry scoring system in adopting nephron-sparing surgery for cT1 renal cancer.
Yasuda Y; Yuasa T; Yamamoto S; Urakami S; Ito M; Sukegawa G; Kitsukawa S; Yonese J; Fukui I
Urol Int; 2013; 90(2):179-83. PubMed ID: 23146865
[TBL] [Abstract][Full Text] [Related]
43. Surgical management of low-stage renal cell carcinoma: Technology does not supersede biology.
Hollingsworth JM; Miller DC; Dunn RL; Montgomery JS; Roberts WW; Hafez KS; Wolf JS
Urology; 2006 Jun; 67(6):1175-80. PubMed ID: 16765177
[TBL] [Abstract][Full Text] [Related]
44. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation.
Chow GK; Myles J; Novick AC
Can J Urol; 2001 Apr; 8(2):1223-8. PubMed ID: 11375785
[TBL] [Abstract][Full Text] [Related]
45. Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.
Rodríguez A; Patard JJ; Lobel B
Arch Esp Urol; 2002 Oct; 55(8):969-75. PubMed ID: 12455292
[TBL] [Abstract][Full Text] [Related]
46. Predicting Renal Parenchymal Loss after Nephron Sparing Surgery.
Meyer A; Woldu SL; Weinberg AC; Thoreson GR; Pierorazio P; Matulay JT; Benson MC; DeCastro GJ; McKiernan JM
J Urol; 2015 Sep; 194(3):658-63. PubMed ID: 25818030
[TBL] [Abstract][Full Text] [Related]
47. Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal Tumors.
Osawa T; Hafez KS; Miller DC; Montgomery JS; Morgan TM; Palapattu GS; Weizer AZ; Caoili EM; Ellis JH; Kunju LP; Wolf JS
J Urol; 2016 Mar; 195(3):574-80. PubMed ID: 26523883
[TBL] [Abstract][Full Text] [Related]
48. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
Kim EH; Jain S; Benway BM; Figenshau RS
BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
[TBL] [Abstract][Full Text] [Related]
49. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
50. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
51. Diameter-axial-polar nephrometry: integration and optimization of R.E.N.A.L. and centrality index scoring systems.
Simmons MN; Hillyer SP; Lee BH; Fergany AF; Kaouk J; Campbell SC
J Urol; 2012 Aug; 188(2):384-90. PubMed ID: 22698624
[TBL] [Abstract][Full Text] [Related]
52. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
53. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
54. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
55. Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Eberhard K; Hoefler G; Pummer K; Zigeuner R
J Clin Pathol; 2012 Aug; 65(8):721-4. PubMed ID: 22639409
[TBL] [Abstract][Full Text] [Related]
56. The initial experience with RENAL Nephrometry in children, adolescents, and young adults with renal tumors.
Cost NG; DeFoor WR; Crotty EJ; Geller JI
Pediatr Blood Cancer; 2014 Aug; 61(8):1434-9. PubMed ID: 24610879
[TBL] [Abstract][Full Text] [Related]
57. R.E.N.A.L. Score Outperforms PADUA Score, C-Index and DAP Score for Outcome Prediction of Nephron Sparing Surgery in a Selected Cohort.
Borgmann H; Reiss AK; Kurosch M; Filmann N; Frees S; Mager R; Tsaur I; Haferkamp A
J Urol; 2016 Sep; 196(3):664-71. PubMed ID: 27091569
[TBL] [Abstract][Full Text] [Related]
58. Trends in the incidence of benign pathological lesions at partial nephrectomy for presumed renal cell carcinoma in renal masses on preoperative computed tomography imaging: a single institute experience with 290 consecutive patients.
Lee SH; Park SU; Rha KH; Choi YD; Hong SJ; Yang SC; Mah SY; Chung BH
Int J Urol; 2010 Jun; 17(6):512-6. PubMed ID: 20345432
[TBL] [Abstract][Full Text] [Related]
59. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
[TBL] [Abstract][Full Text] [Related]
60. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
Shannon BA; Cohen RJ; de Bruto H; Davies RJ
J Urol; 2008 Oct; 180(4):1257-61; discussion 1261. PubMed ID: 18707712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
